Cargando…

Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors

BACKGROUND: We present a family consisting of a father and his two children with an exceptional phenotype of childhood renal cell carcinoma and brain tumors. Extensive genetic testing revealed two inherited tumor predisposition syndromes in all three family members: Birt‐Hogg‐Dubé syndrome and Li‐Fr...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Beek, Irma, Glykofridis, Iris E., Wagner, Anja, den Toom, Dorine T., Bongers, Ernie M. H. F., van Leenders, Geert J. L. H., Johannesma, Paul C., Meijers‐Heijboer, Hanne E. J., Wolthuis, Rob M. F., van Steensel, Maurice A. M., Dubbink, Hendrikus J., Houweling, Arjan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938753/
https://www.ncbi.nlm.nih.gov/pubmed/36382415
http://dx.doi.org/10.1002/mgg3.2098
_version_ 1784890700782895104
author van de Beek, Irma
Glykofridis, Iris E.
Wagner, Anja
den Toom, Dorine T.
Bongers, Ernie M. H. F.
van Leenders, Geert J. L. H.
Johannesma, Paul C.
Meijers‐Heijboer, Hanne E. J.
Wolthuis, Rob M. F.
van Steensel, Maurice A. M.
Dubbink, Hendrikus J.
Houweling, Arjan C.
author_facet van de Beek, Irma
Glykofridis, Iris E.
Wagner, Anja
den Toom, Dorine T.
Bongers, Ernie M. H. F.
van Leenders, Geert J. L. H.
Johannesma, Paul C.
Meijers‐Heijboer, Hanne E. J.
Wolthuis, Rob M. F.
van Steensel, Maurice A. M.
Dubbink, Hendrikus J.
Houweling, Arjan C.
author_sort van de Beek, Irma
collection PubMed
description BACKGROUND: We present a family consisting of a father and his two children with an exceptional phenotype of childhood renal cell carcinoma and brain tumors. Extensive genetic testing revealed two inherited tumor predisposition syndromes in all three family members: Birt‐Hogg‐Dubé syndrome and Li‐Fraumeni syndrome. The corresponding genes (FLCN and TP53) are both located on the short arm of chromosome 17. METHODS: We describe the phenotype and performed single nucleotide polymorphism (SNP)‐based loss of heterozygosity (LOH) analysis of the tumors. RESULTS: All examined tumors showed somatic loss of the wild‐type alleles of both FLCN and TP53. CONCLUSIONS: We hypothesize that a synergistic effect of both mutations caused the unusual phenotype of childhood renal cell carcinoma in this family. This family emphasizes the importance of further genetic testing if a tumor develops at an unexpected young age in an inherited cancer predisposition syndrome.
format Online
Article
Text
id pubmed-9938753
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99387532023-02-19 Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors van de Beek, Irma Glykofridis, Iris E. Wagner, Anja den Toom, Dorine T. Bongers, Ernie M. H. F. van Leenders, Geert J. L. H. Johannesma, Paul C. Meijers‐Heijboer, Hanne E. J. Wolthuis, Rob M. F. van Steensel, Maurice A. M. Dubbink, Hendrikus J. Houweling, Arjan C. Mol Genet Genomic Med Original Articles BACKGROUND: We present a family consisting of a father and his two children with an exceptional phenotype of childhood renal cell carcinoma and brain tumors. Extensive genetic testing revealed two inherited tumor predisposition syndromes in all three family members: Birt‐Hogg‐Dubé syndrome and Li‐Fraumeni syndrome. The corresponding genes (FLCN and TP53) are both located on the short arm of chromosome 17. METHODS: We describe the phenotype and performed single nucleotide polymorphism (SNP)‐based loss of heterozygosity (LOH) analysis of the tumors. RESULTS: All examined tumors showed somatic loss of the wild‐type alleles of both FLCN and TP53. CONCLUSIONS: We hypothesize that a synergistic effect of both mutations caused the unusual phenotype of childhood renal cell carcinoma in this family. This family emphasizes the importance of further genetic testing if a tumor develops at an unexpected young age in an inherited cancer predisposition syndrome. John Wiley and Sons Inc. 2022-11-16 /pmc/articles/PMC9938753/ /pubmed/36382415 http://dx.doi.org/10.1002/mgg3.2098 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
van de Beek, Irma
Glykofridis, Iris E.
Wagner, Anja
den Toom, Dorine T.
Bongers, Ernie M. H. F.
van Leenders, Geert J. L. H.
Johannesma, Paul C.
Meijers‐Heijboer, Hanne E. J.
Wolthuis, Rob M. F.
van Steensel, Maurice A. M.
Dubbink, Hendrikus J.
Houweling, Arjan C.
Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
title Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
title_full Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
title_fullStr Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
title_full_unstemmed Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
title_short Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
title_sort combined germline pathogenic variants in flcn and tp53 are associated with early onset renal cell carcinoma and brain tumors
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938753/
https://www.ncbi.nlm.nih.gov/pubmed/36382415
http://dx.doi.org/10.1002/mgg3.2098
work_keys_str_mv AT vandebeekirma combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT glykofridisirise combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT wagneranja combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT dentoomdorinet combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT bongerserniemhf combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT vanleendersgeertjlh combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT johannesmapaulc combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT meijersheijboerhanneej combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT wolthuisrobmf combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT vansteenselmauriceam combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT dubbinkhendrikusj combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors
AT houwelingarjanc combinedgermlinepathogenicvariantsinflcnandtp53areassociatedwithearlyonsetrenalcellcarcinomaandbraintumors